BrainSightAI raises $5 M in Pre-series A funding round to expand presence in India

Increasing its reach in Tier 1 cities and extend to Tier 2 cities

BrainSight AI, a Bengaluru-based deep-tech neuroscience startup, has raised Pre-series A funding with $5 million led by IAN Alpha Fund, with participation from IvyCap Ventures, Silver Needle, apart from existing investors. The funding is a significant milestone in BrainSightAI’s mission to revolutionise the diagnosis and treatment of complex brain disorders through its innovative neuroinformatics platform, VoxelBox.

Currently, BrainSightAI collaborates with over 40 leading hospitals across India, particularly in neurosurgery and radiology departments, focusing on brain tumour cases. The company is now expanding its solutions to neurological and psychiatric disorders, paving the way for a more holistic approach to brain care.

The funds from this round will be strategically utilised to expand BrainSightAI’s presence in India, increasing its reach in Tier 1 cities and extend to Tier 2 cities. The company also plans to pursue FDA certification, opening access to the US and allied markets. Additionally, the company is gearing up to explore opportunities in Africa and Southeast Asia, based on distributor interest. The funds will also support R&D for a caregiver-focused app, aimed at empowering families of patients with brain disorders.

BrainSightAI is at the forefront of understanding how the physiology of the brain correlates to its functions by mapping macro-scale neural connections in the brain, to enable precise diagnosis and prognosis of neuro-oncological and neuropsychiatric disorders. Traditionally available only at leading global research institutions like Harvard and Stanford, the platform makes this cutting-edge technology accessible to hospitals and patients worldwide.

Published on : 09th January, 2025